Psychiatric Hospitals in Australia - Industry Market Research Report (Related Reports)

Psychiatric Hospitals in Australia - Industry Market Research Report


December 3, 2012
28 Pages - SKU: IBSS4959593
License type:
Online Download      US $970.00
Global Site License      US $2,425.00
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia
4/15/2014 | published by: GlobalData
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia Summary GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Malaysia”. The report is an essential source of information and analysis  |  read more...
$1,995.00
Healthcare Building Construction in Bahrain to 2018: Market Databook
4/22/2014 | published by: Timetric
Synopsis Timetric’s 'Healthcare Building Construction in Bahrain to 2018: Market Databook' contains detailed historic and forecast market value data for the healthcare building construction industry, including a breakdown of the data by construction activity (new construction,  |  read more...
$500.00
Cambodia and Laos Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
Cambodia and Laos Pharmaceuticals and Healthcare Report Q2 2014 BMI View: Low health and pharmaceutical expenditures will continue to limit the attractiveness of thepharmaceutical market in Cambodia. Given such a profile, the country will present more  |  read more...
$1,295.00
Bahrain Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
Bahrain Pharmaceuticals and Healthcare Report Q2 2014 BMI View: This quarter has seen the beginning of a multi-phased plan by the National Health RegulatoryAuthority to significantly reduce medicine prices in the country, signalling a potential advancement  |  read more...
$1,295.00
Denmark Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
Denmark Pharmaceuticals and Healthcare Report Q2 2014 BMI View: Although Denmark's pharmaceutical market is relatively small compared to other WesternEuropean countries, the demand for high quality healthcare will remain elevated by an increasing andageing population. This  |  read more...
$1,295.00
Iraq Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
Iraq Pharmaceuticals and Healthcare Report Q2 2014 BMI View: The projected growth of Iraq's pharmaceutical market in 2014 and 2015 is linked to an oildriveneconomic expansion, which is dependent on the government's ability to represent and  |  read more...
$1,295.00
Lithuania Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
Lithuania Pharmaceuticals and Healthcare Report Q2 2014 BMI View: We expect the Lithuanian pharmaceutical market to post a five-year compound annual growthrate (CAGR) of 4.4%, rising to a value of LTL2.16bn (US$751mn) in 2018. While double-digit  |  read more...
$1,295.00
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
Sri Lanka Pharmaceuticals and Healthcare Report Q2 2014 BMI View: A better-than-expected outlook for Sri Lanka's economy has led us to upwardly revise ourpharmaceutical and healthcare forecasts. The government has introduced price controls on wholesale andretail  |  read more...
$1,295.00
Venezuela Pharmaceuticals and Healthcare Report Q2 2014
4/16/2014 | published by: Business Monitor International
Venezuela Pharmaceuticals and Healthcare Report Q2 2014 BMI View: Foreign currency controls and drug price cuts will continue to affect pharmaceutical companies'profitability, with the currency devaluation and high inflation exacerbating the situation. A closerelationship and effective  |  read more...
$1,295.00
Greece Pharmaceuticals and Healthcare Report Q2 2014
4/23/2014 | published by: Business Monitor International
Greece Pharmaceuticals and Healthcare Report Q2 2014 BMI View: Despite the Greek economy's expected return to growth in 2014, we expect no lessening in thepressures on the Greek pharmaceutical and healthcare sectors over the medium- to  |  read more...
$1,295.00